Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Matleverans, fjärrövervakning och coachingförbättrad utbildning för optimerad diabeteshantering (FREEDOM) (FREEDOM)

18 september 2026 uppdaterad av: Tapan Shirish Mehta, University of Alabama at Birmingham

Brief Summary:

The FREEDOM study aims to develop a scalable intervention to improve type 2 diabetes mellitus control in low-income Black adults in the Deep South. The intervention targets social determinants of health (SDoH) such as reduced healthcare access, poverty, transportation barriers, and food insecurity.

Studieöversikt

Detaljerad beskrivning

Detailed Description:

  1. FREEDOM Study (Type 2 Diabetes Mellitus):

    The FREEDOM study is a 12-month clinical trial enrolling 304 Black adults with Type 2 Diabetes Mellitus across three healthcare systems in Alabama and Mississippi. Participants are randomly assigned to one of eight combinations of three intervention components:

    • Digital Health Coaching: Participants receive one-on-one phone-based coaching for optimized diabetes management.
    • Food Box Delivery: Food boxes are delivered every two weeks to participants' homes,
    • Remote Patient Monitoring (RPM): Participants receive essential supplies, including glucometers, for remote blood glucose measurement. Data is monitored remotely for timely interventions.

    The study involves three in-person visits at baseline, month 6, and month 12, as well as two telephone study check-ins at month 3 and 9. Survey packets are administered at each time point.

  2. FREEDOM-HIV Study (Type 2 Diabetes Mellitus and HIV Cohort):

Additionally, a cohort within the study, known as the FREEDOM-HIV study, will enroll additional 80 adults who have both Type 2 Diabetes Mellitus and HIV. This cohort will be observed over a 6-month period and will also consist of the same three intervention components.

Studietyp

Interventionell

Inskrivning (Faktisk)

304

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Alabama
      • Birmingham, Alabama, Förenta staterna, 35205
        • UAB Hospital and UMMC Cardiology Clinics

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år och äldre (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion criteria:

  1. Self-identified as Black/African American
  2. ICD diagnosis of T2DM
  3. ≥18 years of age
  4. Ongoing insulin treatment
  5. HbA1c ≥8% within 6 weeks of study screening
  6. has the ability to converse in and read English
  7. must provide written informed consent prior to enrollment

Exclusion criteria:

  1. Current enrollment in any diabetes-related interventional study
  2. Cognitive impairment
  3. End-stage kidney disease (CKD-5)
  4. Pregnant or plans to become pregnant within 12 months
  5. Currently enrolled in a structured lifestyle change program
  6. Enrolled in remote patient monitoring or health coaching within 60 days of the study or intervention

HIV Cohort Criteria

Inclusion Criteria

  1. ≥ 18 years of age
  2. ICD diagnosis of T2DM
  3. HbA1c ≥ 7%
  4. Confirmed HIV+ diagnosis
  5. Prescribed HIV ART therapy as part of care

Exclusion Criteria

  1. Current enrollment in any diabetes-related interventional study or structured lifestyle change program
  2. Enrolled in RPM or health coaching (except for coaching on smoking cessation) within 60 days of the intervention
  3. Cognitive impairment
  4. End-stage kidney disease (CKD-5)
  5. Pregnant or plans to become pregnant within 12 months

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Stödjande vård
  • Tilldelning: Randomiserad
  • Interventionsmodell: Faktoriell uppgift
  • Maskning: Enda

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Arm 1

Digital coaching+ Food delivery+ RPM

The digital health coaching intervention program involves an evidence-based curriculum and one-on-one support to promote positive health behaviors and patient self-management of diabetes.

The food box intervention component will consist of biweekly food boxes delivered directly to participants over the course of 6 months. The food boxes will contain shelf-stable groceries that adhere to ADA nutritional guidelines for individuals with T2DM.

The RPM team will instruct the participants to monitor blood glucose levels 3 times daily. Glucose levels will be monitored 8 a.m. to 5 p.m.Monday to Friday. Data summaries will be reviewed bi-monthly with RNs and pharmacists. Participants will be provided with a glucometer, test strips, and mobile divide to record their blood glucose levels.

The diabetes education class will be administered by a certified diabetes educator.

Aktiv komparator: Arm 2

Digital coaching

The digital health coaching intervention program involves an evidence-based curriculum and one-on-one support to promote positive health behaviors and patient self-management of diabetes.

The diabetes education class will be administered by a certified diabetes educator.

Aktiv komparator: Arm 3

Digital coaching+ Food delivery

The digital health coaching intervention program involves an evidence-based curriculum and one-on-one support to promote positive health behaviors and patient self-management of diabetes.

The food box intervention component will consist of biweekly food boxes delivered directly to participants over the course of 6 months. The food boxes will contain shelf-stable groceries that adhere to ADA nutritional guidelines for individuals with T2DM.

The diabetes education class will be administered by a certified diabetes educator.

Aktiv komparator: Arm 4

Digital coaching+ RPM

The digital health coaching intervention program involves an evidence-based curriculum and one-on-one support to promote positive health behaviors and patient self-management of diabetes.

The RPM team will instruct the participants to monitor blood glucose levels 3 times daily. Glucose levels will be monitored 8 a.m. to 5 p.m.Monday to Friday. Data summaries will be reviewed bi-monthly with RNs and pharmacists. Participants will be provided with a glucometer, test strips, and mobile divide to record their blood glucose levels.

The diabetes education class will be administered by a certified diabetes educator.

Aktiv komparator: Arm 5

Food delivery+ RPM

The food box intervention component will consist of biweekly food boxes delivered directly to participants over the course of 6 months. The food boxes will contain shelf-stable groceries that adhere to ADA nutritional guidelines for individuals with T2DM.

The RPM team will instruct the participants to monitor blood glucose levels 3 times daily. Glucose levels will be monitored 8 a.m. to 5 p.m.Monday to Friday. Data summaries will be reviewed bi-monthly with RNs and pharmacists. Participants will be provided with a glucometer, test strips, and mobile divide to record their blood glucose levels.

The diabetes education class will be administered by a certified diabetes educator.

Aktiv komparator: Arm 6

The participant's will not receive any Intervention

The diabetes education class will be administered by a certified diabetes educator.

Aktiv komparator: Arm 7

Food delivery

The food box intervention component will consist of biweekly food boxes delivered directly to participants over the course of 6 months. The food boxes will contain shelf-stable groceries that adhere to ADA nutritional guidelines for individuals with T2DM.

The diabetes education class will be administered by a certified diabetes educator.

Aktiv komparator: Arm 8

RPM

The RPM team will instruct the participants to monitor blood glucose levels 3 times daily. Glucose levels will be monitored 8 a.m. to 5 p.m.Monday to Friday. Data summaries will be reviewed bi-monthly with RNs and pharmacists. Participants will be provided with a glucometer, test strips, and mobile divide to record their blood glucose levels.

The diabetes education class will be administered by a certified diabetes educator.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
FREEDOM Study: Change in HbA1c level between baseline and 12 month
Tidsram: 12 months

The primary outcome of the study is to track change in the HbA1c between baseline and 12 months (endpoint of the study). The HbA1C will be tested at baseline, 6 and 12 months.

12 months
Primary Outcome for the HIV Cohort: Change in HbA1c level between baseline and 6 months
Tidsram: 6 months

The primary outcome of the study is to track change in the HbA1c between baseline and 6 months (endpoint of the study). The HbA1C will be tested at baseline and 6 months.

6 months

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

5 januari 2023

Primärt slutförande (Faktisk)

21 juli 2026

Avslutad studie (Faktisk)

30 augusti 2026

Studieregistreringsdatum

Först inskickad

17 februari 2022

Först inskickad som uppfyllde QC-kriterierna

10 mars 2022

Första postat (Faktisk)

21 mars 2022

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

22 september 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

18 september 2026

Senast verifierad

1 september 2026

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera